Carol Giltner Gallagher

Insider Reports History

Identity 1 identity field
Location
Del Mar, CA
SEC filing record 1 source field
SEC signature
/s/ John Chao, Attorney-in-Fact for Carol Gallagher
SEC evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Carol Giltner Gallagher

Form 4 holding Director

Certara, Inc.

Security class
Common Stock
Shares / value
7,059
Estimated value
$127,062
Report date
15 Jun 2021
Price
$18.00
Ownership
Direct
Form 4 holding Director

Frazier Lifesciences Acquisition Corp

Security class
Class B Ordinary Shares
Shares / value
0
Estimated value
Report date
22 Nov 2022
Price
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount
Form 4 holding Director

Mirati Therapeutics, Inc.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
23 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Turning Point Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
17 Aug 2022
Price
Ownership
By the Gallagher Revocable Trust dated May 10, 2011
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Turning Point Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
17 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Carol Giltner Gallagher

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .